Clinical Trial Update: Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed in combination with oxaliplatin for recurrent non-small cell lung cancer after platinum-based adjuvant failure was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-04-20